%0 Generic
%T Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease : A Phase I, Randomized, Placebo-Controlled, Double-Blind, Dose-Escalation Study A Phase I, Randomized, Placebo-Controlled, Double-Blind, Dose-Escalation Study
%A Landen, Jaren W.
%A Zhao, Qinying
%A Cohen, Sharon
%A Borrie, Michael
%A Woodward, Michael
%A Billing, Clare B.
%A Bales, Kelly
%A Alvey, Christine
%A McCush, Fred
%A Yang, Jerry
%A Kupiec, James W.
%A Bednar, Martin M.
%I Ovid Technologies (Wolters Kluwer Health)
%@ 0362-5664
%D 2013
%C Ovid Technologies (Wolters Kluwer Health)
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation